Plasma P-selectin is increased in thrombotic consumptive platelet disorders.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood.v83.6.1535.1535PMID 7510145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of plasma alpha-granule membrane protein GMP-140 using radiolabeled monoclonal antibodies in thrombotic diseases.

  1993cited by this paper
• Characterization of GMP-140 (P-selectin) as a circulating plasma protein

  1992cited by this paper
• Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway.

  1992cited by this paper
• Leukocyte Interactions Mediated by Selectins

  1991cited by this paper
• GMP-140 binding to neutrophils is inhibited by sulfated glycans.

  1991cited by this paper
• Measurement of platelet activation by fluorescence-activated flow cytometry.

  1990cited by this paper
• Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin.

  1990cited by this paper
• Direct detection of activated platelets and platelet-derived microparticles in humans.

  1990cited by this paper
• Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes.

  1990cited by this paper
• Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation.

  1989cited by this paper
• Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

  1989cited by this paper
• Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets.

  1989cited by this paper
• A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein.

  1986cited by this paper
• 10 – Secreted Platelet Proteins as Markers for Pathological Disorders*

  1986cited by this paper
• 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.

  1986cited by this paper
• Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

  1986cited by this paper
• Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction.

  1985cited by this paper
• An altered platelet granule glycoprotein in patients with essential thrombocythemia.

  1984cited by this paper
• Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

  1981cited by this paper
• Beta-thromboglobulin is elevated in renal failure without thrombosis.

  1980cited by this paper
• Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia.

  1980cited by this paper
• Evidence for the Platelet Specificity of β‐Thromboglobulin and Studies on its Plasma Concentration in Healthy Individuals

  1979cited by this paper
• The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4.

  1978cited by this paper

• Venom-Induced Recurrent Thrombocytopenia: A Model of Intervention-Driven Platelet Modulation

  2025cites this paper
• Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?

  2025cites this paper
• P-Selectin(g) a diagnostic biomarker in heparin-induced thrombocytopenia.

  2025cites this paper
• Shedding light on GPIbα shedding

  2024cites this paper
• Cancer progression and tumor hypercoagulability: a platelet perspective

  2024cites this paper
• Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia

  2024cites this paper
• Is Endothelial Activation a Critical Event in Thrombotic Thrombocytopenic Purpura?

  2023influential citation
• Reversible and transient thrombocytopenia of functional platelets induced by nose-horned viper venom.

  2023cites this paper
• Adhesion Molecules as Prognostic Biomarkers in Coronary Artery Disease.

  2023cites this paper
• Soluble P-Selectin and von Willebrand Factor Rise in Healthy Volunteers Following Non-exertional Ascent to High Altitude

  2022cites this paper
• The utility of platelet activation biomarkers in thrombotic microangiopathies

  2022cites this paper
• Neutrophil Extracellular Traps Induced by Shiga Toxin and Lipopolysaccharide-Treated Platelets Exacerbate Endothelial Cell Damage

  2022cites this paper
• The endothelium as a target for bacterial infection: challenges at the bedside

  2021cites this paper
• Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia

  2021influential citation
• Release of α-granule contents during platelet activation

  2021cites this paper
• Coagulation disorders in Chagas disease: A pathophysiological systematic review and meta-analysis.

  2021cites this paper
• Extracellular Vesicle-Associated Tissue Factor Activity in Prostate Cancer Patients with Disseminated Intravascular Coagulation

  2021cites this paper
• Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia

  2020cites this paper
• Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review

  2020cites this paper
• COVID-19 versus HIT hypercoagulability

  2020cites this paper
• Potential Role of Platelet-Activating C-Type Lectin-Like Proteins in Viper Envenomation Induced Thrombotic Microangiopathy Symptom

  2020cites this paper
• Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever

  2020cites this paper
• Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.

  2019cites this paper
• Clinical Tests of Platelet Function

  2019cites this paper
• Platelet function in disseminated intravascular coagulation: A systematic review

  2018cites this paper
• PLATELET STORAGE LESION: ROLE OF CD62 (P-SELECTIN)

  2018cites this paper
• Monitoring Antiplatelet Therapy

  2017cites this paper
• The Effect of Treatment of Vitamin D Deficiency on the Level of P‐Selectin and hs‐CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial

  2017cites this paper
• Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis

  2017cites this paper
• Regulation of platelet membrane protein shedding in health and disease

  2017cites this paper
• Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review

  2017cites this paper
• Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group

  2016cites this paper
• Soluble P-selectin rescues viper venom–induced mortality through anti-inflammatory properties and PSGL-1 pathway-mediated correction of hemostasis

  2016cites this paper
• Novel association of soluble intercellular adhesion molecule 1 and soluble P-selectin with the ABO blood group in a Chinese population

  2016cites this paper
• The Alternative Pathway of Complement and the Evolving Clinical‐Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome

  2016influential citation
• Heparin-Induced Thrombocytopenia.

  2015cites this paper
• The platelet serotonin‐release assay

  2015cites this paper
• In vitro assessment of platelet lesions during 5-day storage in Iranian Blood Transfusion Organization (IBTO) centers.

  2015cites this paper
• The association of the Thr715Pro P‐selectin genotype with levels of P‐selectin in platelet concentrates

  2014cites this paper
• Biomarkers for arterial and venous thrombotic disorders

  2014cites this paper
• Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population

  2014cites this paper
• Detection of Platelet-Monocyte Aggregates by the ADAM® Image Cytometer

  2014influential citation
• Impact of variables of the P-selectin – P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease

  2014cites this paper
• Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.

  2014cites this paper
• Testing platelet function.

  2013cites this paper
• Effect of Conversion from ESA with Shorter Half-Life to CERA Once Monthly for Maintaining Hb Concentration in Pre-Dialysis CKD Patients

  2013cites this paper
• Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy

  2013cites this paper
• Hemocompatibility Assessment of 3C-SiC for Cardiovascular Applications

  2012cites this paper
• The Thr715Pro variant impairs terminal glycosylation of P-selectin

  2012cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

  2012cites this paper
• Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression

  2012cites this paper
• Accuracy of a prediction model for heparin-induced thrombocytopenia (HIT): an analysis based on individual patient data.

  2011cites this paper
• Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration

  2011cites this paper
• The influence of bevacizumab on platelet function.

  2011cites this paper
• Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis.

  2011cites this paper
• Heparin-induced thrombocytopenia

  2010cites this paper
• The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia.

  2010cites this paper
• Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin.

  2010cites this paper
• In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.

  2010cites this paper
• Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis.

  2009cites this paper
• Heparin‐induced thrombocytopenia

  2009cites this paper
• Studies of the immune response in heparin-induced thrombocytopenia.

  2009cites this paper
• Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review

  2008cites this paper
• Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphism.

  2008cites this paper
• Soluble but Not Platelet P-selectin Correlates With Spontaneous Platelet Aggregation: A Pilot Study

  2008cites this paper
• Microparticle-associated P-selectin reflects platelet activation in preeclampsia

  2007cites this paper
• Platelet activation in acute pulmonary embolism

  2007cites this paper
• Thrombosis and thrombolysis: platelet membrane glycoproteins.

  2007cites this paper
• Elevation of rat plasma P-selectin in acute lung injury.

  2007cites this paper
• Cell-derived microparticles and exosomes in neuroinflammatory disorders.

  2007cites this paper
• Management of thromboembolism in hematologic malignancies.

  2007cites this paper
• Management of Thromboembolism in Hematologic Malignancies

  2007cites this paper
• Increased levels of soluble P-selectin correlate with iron overload in sickle cell disease

  2007cites this paper
• Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

  2006cites this paper
• Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages.

  2006cites this paper
• Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling.

  2006cites this paper
• The survival and function of baboon red blood cells, platelets, and plasma proteins: a review of the experience from 1972 to 2002 at the Naval Blood Research Laboratory, Boston, Massachusetts

  2006cites this paper
• Testing for heparin-induced thrombocytopenia antibodies.

  2006cites this paper
• Soluble P-selectin concentration in patients with colorectal cancer.

  2005cites this paper
• The P‐selectin, tissue factor, coagulation triad

  2005cites this paper
• Increased Levels of Soluble Adhesion Molecules E-Selectin and P-Selectin in Patients with Cardiac Syndrome X

  2005cites this paper
• Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?

  2005cites this paper
• Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.

  2005cites this paper
• Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.

  2005cites this paper
• Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.

  2005cites this paper
• Thrombocytopenic conditions—autoimmunity and hypercoagulability: Commonalities and differences in ITP, TTP, HIT, and APS

  2005cites this paper
• Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function

  2005cites this paper
• High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men

  2005cites this paper
• The emerging value of P-selectin as a disease marker

  2004cites this paper
• Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.

  2004cites this paper
• An overview of the heparin-induced thrombocytopenia syndrome.

  2004cites this paper
• Warfarin‐associated multiple digital necrosis complicating heparin‐induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma‐associated thrombotic endocarditis

  2004cites this paper
• An Overview of the Heparin-Induced Thrombocytopenia Syndrome

  2004cites this paper
• Endothelial microparticles as markers of endothelial dysfunction.

  2004cites this paper
• Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease

  2004cites this paper
• Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cites this paper
• Prognostic value of soluble P‐selectin levels in colorectal cancer

  2004cites this paper
• A new role in hemostasis for the adhesion receptor P-selectin.

  2004cites this paper
• Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia

  2004cites this paper